---
layout: theophylline_style
title: Tobramycin aptamer
date: 2024-04-24 00:00:00
author: Linfei Li, Ke Chen
categories: Aptamer
tags:
- Category:Pharmaceuticals
- GC:45.87
- GC:47.0
- GC:50.0
- GC:50.46000000000001
- GC:51.38
- GC:59.0
- Length:109
- Length:23
- Length:27
- Length:30
- Named:Tobramycin_J6
- Named:Tobramycin_J6sl (Tobramycin aptamer I)
- Named:Tobramycin_Tobramycin aptamer II
- Named:Tobramycin_W13 (clone 8)
- Named:Tobramycin_X1
- Named:Tobramycin_X1sl
- Type:Small molecules
- Year:1995
type: Small molecules
---
<html>

<div class="side-nav">
<ul>
    <div class="side-nav-item"><li><a href="#timeline" style="color: #000000;">Timeline</a></li></div>
    <div class="side-nav-item"><li><a href="#description" style="color: #000000;">Description</a></li></div>
    <div class="side-nav-item"><li><a href="#SELEX" style="color: #000000;">SELEX</a></li></div>
    <div class="side-nav-item"><li><a href="#Structure" style="color: #000000;">Structure</a></li></div>
    <div class="side-nav-item"><li><a href="#ligand-recognition" style="color: #000000;">Ligand information</a></li></div>
    <div class="side-nav-item"><li><a href="#references" style="color: #000000;">References</a></li></div>
    </ul>
</div>



<p class="header_box" id="timeline">Timeline</p>
<div class="timeline">
  <div class="entry">
    <div class="title">
      <h3><a href="https://pubmed.ncbi.nlm.nih.gov/9383430/" target="_blank" style="color:#520049">1995</a></h3>
    </div>
    <div class="body">
      <p>The aminoglycoside tobramycin has been found to be readily selectively bound by RNA molecules<sup>[<a href="#ref1" style="color:#520049">1</a>]</sup></p>
    </div>
  </div>
  <div class="entry">
    <div class="title">
      <h3><a href="https://pubmed.ncbi.nlm.nih.gov/9070426/" target="_blank" style="color:#520049">1997</a></h3>
    </div>
    <div class="body">
      <p>Described a solution-structure determination of the tobramycin-RNA aptamer complex, obtained using NMR and molecular dynamics<sup>[<a href="#ref2" style="color:#520049">2</a>]</sup></p>
    </div>
  </div>
  <div class="entry">
    <div class="title">
      <h3><a href="https://pubmed.ncbi.nlm.nih.gov/9731769/" target="_blank" style="color:#520049">1998</a></h3>
    </div>
    <div class="body">
      <p>Solved the solution structure of the aminoglycoside antibiotic tobramycin complexed with a stem-loop RNA aptamer<sup>[<a href="#ref3" style="color:#520049">3</a>]</sup></p>
    </div>
  </div>
  <div class="entry">
    <div class="title">
      <h3><a href="https://pubmed.ncbi.nlm.nih.gov/25835184/" target="_blank" style="color:#520049">2015</a></h3>
    </div>
    <div class="body">
      <p>A method of modifying an existing high-gain aptamer sequence to create an aptamer-based electrochemical sensor with reduced affinity for tobramycin<sup>[<a href="#ref7" style="color:#520049">7</a>]</sup></p>
    </div>
  </div>
<div class="entry">
    <div class="title">
      <h3><a href="https://pubmed.ncbi.nlm.nih.gov/30356136/" target="_blank" style="color:#520049">2018</a></h3>
    </div>
    <div class="body">
      <p>The RNA aptamers can selectively increase the intracellular free concentrations of their respective ligands<sup>[<a href="#ref9" style="color:#520049">9</a>]</sup></p>
    </div>
  </div>
  <div class="entry">
    <div class="title">
      <h3><a href="https://pubmed.ncbi.nlm.nih.gov/30268963/" target="_blank" style="color:#520049">2018</a></h3>
    </div>
    <div class="body">
      <p>A tobramycin-specific aptamer with a length of only 15 nucleotides has been obtained<sup>[<a href="#ref10" style="color:#520049">10</a>]</sup></p>
    </div>
  </div>
   <div class="entry">
    <div class="title">
      <h3><a href="https://pubmed.ncbi.nlm.nih.gov/35217273/" target="_blank" style="color:#520049">2022</a></h3>
    </div>
    <div class="body">
      <p>A novel aptasensor for tobramycin was constructed<sup>[<a href="#ref12" style="color:#520049">12</a>]</sup></p>
    </div>
  </div>
   <div class="entry">
    <div class="title">
      <h3><a href="https://pubmed.ncbi.nlm.nih.gov/37791877/" target="_blank" style="color:#520049">2023</a></h3>
    </div>
    <div class="body">
      <p>The selection and characterization of a new riboswitch dependent on the aminoglycoside tobramycin<sup>[<a href="#ref13" style="color:#520049">13</a>]</sup></p>
    </div>
  </div>
</div>


         
<p class="header_box" id="description">Description</p>
<p>Tobramycin aptamers, a class of high-affinity RNA molecules obtained through in vitro selection, were found to exhibit specific recognition of the aminoglycoside antibiotic tobramycin. Research demonstrated that these aptamers formed binding pockets via distinctive stem-loop structures. These structures adopted a "zipper-like" fold, which broadened the RNA's major groove geometry through the synergistic arrangement of mismatched base pairs (e.g., G•U, U•U) and Watson-Crick base pairs (e.g., U•A). Tobramycin was positioned within the RNA's major groove, partially encapsulated between the groove's base and protruding bases (e.g., G15 or C15), forming a semi-enclosed chamber. Its binding was stabilised by hydrogen bonding and electrostatic interactions. For instance, the amino groups (NH₃⁺) of tobramycin could form hydrogen-bond networks with RNA base edges (e.g., N7, O4) or the phosphate backbone, while its aminosugar ring III enhanced binding through hydrophobic interactions with non-polar pyrimidine rings. Selection experiments revealed that high-affinity aptamers (with Kd values in the nM range) possessed highly conserved sequences. Their core binding domains were concentrated within predicted stem-loop regions, with affinity directly correlated to stem-loop stability. Quantitative analyses using fluorescently labelled tobramycin analogues (e.g., PYT) indicated that aptamers exhibited cross-binding capability with structurally similar aminoglycosides (e.g., neomycin), but no significant interaction with non-aminoglycoside antibiotics (e.g., erythromycin), underscoring their specificity. These studies not only elucidated the molecular mechanisms underlying RNA-aminoglycoside interactions but also provided critical insights for antibiotic optimisation and the design of novel RNA-targeted therapeutics informed by structural data<sup>[<a href="#ref1" style="color:#520049">1</a></sup><sup>,<a href="#ref2" style="color:#520049">2</a></sup><sup>,<a href="#ref3" style="color:#520049">3</a></sup><sup>]</sup>.<br></p>



<p class="header_box" id="SELEX">SELEX</p>
<p>An RNA diversity library was employed to select sequences capable of binding to the aminoglycoside antibiotic tobramycin. After six cycles of selection, 82% of the RNA bound specifically to tobramycin. The selected RNA was then reverse-transcribed into DNA and subsequently cloned. At low selection stringency, an extremely large number of clones, on the order of 10⁷, produced RNAs capable of binding tobramycin with dissociation constants (Kd) in the µM range. These values were similar to those observed for the binding of tobramycin to Escherichia coli ribosomes. Sequencing of 18 of these clones revealed no obvious consensus sequence. However, at higher selection stringencies (with Kd values in the nM range), only two consensus sequences for binding were observed<sup>[<a href="#ref1" style="color:#520049">1</a>]</sup>.</p>
<p>
<br>
<br>  



<p class="header_box" id="Structure">Structure</p>
<p class="blowheader_box">2D representation</p>
<p>Here we used ribodraw to complete the figure, through the 3D structure information<sup>[<a href="#ref2" style="color:#520049">2</a>,<a href="#ref3" style="color:#520049">3</a>]</sup>.</p>
<p>5'-GGCACGAGGUUUAGCUACACUCGUGCC-3'</p>
<p>5'-ACUUGGUUUAGGUAAUGAGU-3'</p>
<table class="table table-bordered" style="table-layout:fixed;width:auto;margin-left:auto;margin-right:auto;"><tr>
  <td style="text-align:center;padding-bottom: 0px;padding-left: 0px;padding-top: 0px;padding-right: 0px">
  <img src="/images/2D/Tobramycin_aptamer_2D1.svg" alt="drawing" style="width:500px;height:400px;margin-top: 0px;margin-bottom: 0px;" >
  </td>
  <td style="text-align:center;padding-bottom: 0px;padding-right: 0px;padding-top: 0px;padding-right: 0px">
  <img src="/images/2D/Tobramycin_aptamer_2D2.svg" alt="drawing" style="width:500px;height:400px;margin-top: 0px;margin-bottom: 0px;" >
  </td>
  </tr>
  </table>


<p class="blowheader_box">3D visualisation</p>             
<p>Patel, D. J. et al. described a solution-structure determination of the tobramycin-RNA aptamer I complex, obtained using nuclear magnetic resonance (NMR) and molecular dynamics. The PDB ID of this structure is 1TOB<sup>[<a href="#ref2" style="color:#520049">2</a>]</sup>.</p>
<p>Additional available structures that have been solved and detailed information are accessible on <a href="{{ site.url }}{{ site.baseurl }}/structures" target="_blank" style="color:#520049"><b><i>Structures</i></b></a> page.</p>
<div><p style="text-align:right;margin-bottom: 0px;">(Clicking the "Settings/Controls info" to turn Spin off)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
  <table class="table table-bordered" style="table-layout:fixed;width:1200px;margin-left:auto;margin-right:auto;"><tr>
  <td style="text-align:center;padding-bottom: 0px;padding-left: 0px;padding-top: 0px;padding-right: 0px">
  <img src="/images/3D/Tobramycin_aptamer_3D1.svg" alt="drawing" style="width:500px;margin-top: 0px;margin-bottom: 0px;" >
  </td>
  <td style="text-align:center;padding-bottom: 0px;padding-left: 0px;padding-top: 0px;padding-right: 0px">
  <html lang="en">

      <!-- Molstar CSS & JS -->
      <link rel="stylesheet" type="text/css" href="https://cdn.jsdelivr.net/npm/pdbe-molstar@3.3.0/build/pdbe-molstar.css">
      <script src="https://cdn.jsdelivr.net/npm/pdbe-molstar@3.3.0/build/pdbe-molstar-plugin.js"></script>
        <style>
          * {
              margin: 0;
              padding: 0;
              box-sizing: border-box;
          }
          .msp-plugin ::-webkit-scrollbar-thumb {
              background-color: #474748  !important;
          }
          .msp-plugin .msp-layout-standard {
              border: 1px solid #efefef;
          }
          .viewerSection1 {
            padding-top: 0px;
          }
          .controlsSection1 {
            width: 300px;
              display: flex;
              float:left;
              padding: 0px 0 0 0;
              height:25px;
            }
            .controlBox1 {
              border: 0px solid lightgray;
              padding: 0px;
              margin-bottom: 0px;
            }
          #myViewer1{
            float:left;
            width:500px !important;
            height: 500px !important;
            position:relative;
            min-width: 500px;
            min-height: 500px;
          }
          
          /* 确保Molstar插件不受外部样式影响 */
          .msp-plugin {
            width: 500px !important;
            height: 500px !important;
          }
        </style>
    <body onload="customize()">
        <div class="controlsSection1">
            <button onclick="viewerInstance1.visual.select({ data: selectSections1, nonSelectedColor: {r:255,g:255,b:255}})" style="float:right;height:25px;width: 120px;">Color Selection</button><br><br>
          <button style="float: left;height:25px;width: 120px;" onclick="viewerInstance1.visual.clearSelection()">Clear Selection</button><br><br>
      </div>
    <div class="viewerSection1">
    <!-- Molstar container -->
      <div id="myViewer1"></div>
    </div>
    <script>
      // 预定义选色数据
      const selectSections1 = [
        {
          struct_asym_id: 'A',    
          start_residue_number:1, 
          end_residue_number:6, 
          color:{r:184,g:51,b:50}
        },{
          struct_asym_id: 'A', 
          start_residue_number:7, 
          end_residue_number:7, 
          color:{r:241,g:125,b:7}
        },{
          struct_asym_id: 'A', 
          start_residue_number:8, 
          end_residue_number:8, 
          color:{r:184,g:51,b:50}
        },{
          struct_asym_id: 'A', 
          start_residue_number:9, 
          end_residue_number:9, 
          color:{r:241,g:125,b:7}
        },{
          struct_asym_id: 'A', 
          start_residue_number:10, 
          end_residue_number:11, 
          color:{r:184,g:51,b:50}
        },{
          struct_asym_id: 'A', 
          start_residue_number:12, 
          end_residue_number:12, 
          color:{r:241,g:125,b:7}
        },{
          struct_asym_id: 'A', 
          start_residue_number:13, 
          end_residue_number:14, 
          color:{r:46,g:161,b:3}
        },{
          struct_asym_id: 'A', 
          start_residue_number:15, 
          end_residue_number:15, 
          color:{r:241,g:125,b:7}
        },{
          struct_asym_id: 'A', 
          start_residue_number:16, 
          end_residue_number:27, 
          color:{r:184,g:51,b:50}
        },{
          struct_asym_id: 'C', 
          start_residue_number:28, 
          end_residue_number:30, 
          color:{r:255,g:0,b:255}
        }
      ];

      var viewerInstance1 = new PDBeMolstarPlugin();
      var options1 = {
        customData:{
        url:'/pdbfiles/1TOB.pdb',
        format: 'pdb'},
        hideCanvasControls: ['expand', 'selection', 'animation', 'controlToggle'],
        bgColor: {r:255, g:255, b:255},
        }
      var viewerContainer1 = document.getElementById('myViewer1');
      viewerInstance1.render(viewerContainer1, options1).then(() => {
        // 等待结构加载完成后自动应用颜色
        setTimeout(() => {
          viewerInstance1.visual.select({ 
            data: selectSections1, 
            nonSelectedColor: {r:255,g:255,b:255}
          });
        }, 1000);
      });
</script>
</body>
</html>
</td>
</tr>
</table>
</div>
<br>

<p>Patel, D. J. et al. described the structure of the complex was calculated by NMR and the X-PLOR programme, and molecular dynamics constraints were performed to demonstrate the solution structure of the complex of the aminoglycoside antibiotic tobramycin in conjunction with stem-loop RNA aptamer II. The PDB ID of this structure is 2TOB<sup>[<a href="#ref3" style="color:#520049">3</a>]</sup>.</p>
<p>Additional available structures that have been solved and detailed information are accessible on <a href="{{ site.url }}{{ site.baseurl }}/structures" target="_blank" style="color:#520049"><b><i>Structures</i></b></a> page.</p>
<div><p style="text-align:right;margin-bottom: 0px;">(Clicking the "Settings/Controls info" to turn Spin off)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
  <table class="table table-bordered" style="table-layout:fixed;width:1200px;margin-left:auto;margin-right:auto;"><tr>
  <td style="text-align:center;padding-bottom: 0px;padding-left: 0px;padding-top: 0px;padding-right: 0px">
  <img src="/images/3D/Tobramycin_aptamer_3D2.svg" alt="drawing" style="width:500px;margin-top: 0px;margin-bottom: 0px;" >
  </td>
  <td style="text-align:center;padding-bottom: 0px;padding-left: 0px;padding-top: 0px;padding-right: 0px">
  <html lang="en">
      <!-- Molstar CSS & JS -->
      <link rel="stylesheet" type="text/css" href="https://cdn.jsdelivr.net/npm/pdbe-molstar@3.3.0/build/pdbe-molstar.css">
      <script src="https://cdn.jsdelivr.net/npm/pdbe-molstar@3.3.0/build/pdbe-molstar-plugin.js"></script>
        <style>
          * {
              margin: 0;
              padding: 0;
              box-sizing: border-box;
          }
          .msp-plugin ::-webkit-scrollbar-thumb {
              background-color: #474748  !important;
          }
          .msp-plugin .msp-layout-standard {
              border: 1px solid #efefef;
          }
          .viewerSection2 {
            padding-top: 0px;
          }
          .controlsSection2 {
            width: 300px;
              display: flex;
              float:left;
              padding: 0px 0 0 0;
              height:25px;
            }
            .controlBox2 {
              border: 0px solid lightgray;
              padding: 0px;
              margin-bottom: 0px;
            }
          #myViewer2{
            float:left;
            width:500px;
            height: 500px;
            position:relative;
          }
        </style>

    <body onload="customize()">
        <div class="controlsSection2">
            <button onclick="viewerInstance2.visual.select({ data: selectSections2, nonSelectedColor: {r:255,g:255,b:255}})" style="float:right;height:25px;width: 120px;">Color Selection</button><br><br>
          <button style="float: left;height:25px;width: 120px;" onclick="viewerInstance2.visual.clearSelection()">Clear Selection</button><br><br>
      </div>
    <div class="viewerSection2">
    <!-- Molstar container -->
      <div id="myViewer2"></div>
    </div>
    <script>
      // 预定义选色数据
      const selectSections2 = [
        {
          struct_asym_id: 'A',    
          start_residue_number:4, 
          end_residue_number:6, 
          color:{r:184,g:51,b:50}
        },
        {
          struct_asym_id: 'A', 
          start_residue_number:7, 
          end_residue_number:12, 
          color:{r:241,g:125,b:7}
        },
        {
          struct_asym_id: 'A', 
          start_residue_number:13, 
          end_residue_number:14, 
          color:{r:46,g:161,b:3}
        },
        {
          struct_asym_id: 'A', 
          start_residue_number:15, 
          end_residue_number:15, 
          color:{r:241,g:125,b:7}
        },
        {
          struct_asym_id: 'A', 
          start_residue_number:16, 
          end_residue_number:18, 
          color:{r:184,g:51,b:50}
        },
        {
          struct_asym_id: 'A', 
          start_residue_number:19, 
          end_residue_number:19, 
          color:{r:241,g:125,b:7}
        },
        {
          struct_asym_id: 'A', 
          start_residue_number:20, 
          end_residue_number:23, 
          color:{r:184,g:51,b:50}
        },
        {
          struct_asym_id: 'C', 
          start_residue_number:100, 
          end_residue_number:102, 
          color:{r:255,g:0,b:255}
        }
      ];

      var viewerInstance2 = new PDBeMolstarPlugin();
      var options2 = {
        customData:{
        url:'/pdbfiles/2TOB.pdb',
        format: 'pdb'},
        hideCanvasControls: ['expand', 'selection', 'animation', 'controlToggle'],
        bgColor: {r:255, g:255, b:255},
        }
      var viewerContainer2 = document.getElementById('myViewer2');
      viewerInstance2.render(viewerContainer2, options2).then(() => {
        // 等待结构加载完成后自动应用颜色
        setTimeout(() => {
          viewerInstance2.visual.select({ 
            data: selectSections2, 
            nonSelectedColor: {r:255,g:255,b:255}
          });
        }, 1000);
      });
</script>
</body>
</html>
</td>
</tr>
</table>
</div>
<br>



<p class="blowheader_box">Binding pocket</p>             
<p>Left: Surface representation of the binding pocket of the aptamer generated from PDB ID: 1TOB by NMR. TOB (shown in sticks) is labeled in magenta. Right: The hydrogen bonds of binding sites of the aptamer bound with TOB.</p>
  <table class="table table-bordered" style="table-layout:fixed;width:1200px;margin-left:auto;margin-right:auto;"><tr>
  <td style="text-align:center;padding-bottom: 0px;padding-left: 0px;padding-top: 0px;padding-right: 0px">
  <img src="/images/Binding_pocket/Tobramycin_aptamer_binding_pocker1.svg" alt="drawing" style="width:500px;margin-top: 0px;margin-bottom: 0px;" >
  </td>
  <td style="text-align:center;padding-bottom: 0px;padding-right: 0px;padding-top: 0px;padding-right: 0px">
  <img src="/images/Binding_pocket/Tobramycin_aptamer_binding_pocker2.svg" alt="drawing" style="width:500px;margin-top: 0px;margin-bottom: 0px;" >
  </td>
  </tr>
  </table>
  <br>
            
<p>Left: Surface representation of the binding pocket of the aptamer generated from PDB ID: 2TOB by NMR. TOB (shown in sticks) is labeled in magenta. Right: The hydrogen bonds of binding sites of the aptamer bound with TOB.</p>
  <table class="table table-bordered" style="table-layout:fixed;width:1200px;margin-left:auto;margin-right:auto;"><tr>
  <td style="text-align:center;padding-bottom: 0px;padding-left: 0px;padding-top: 0px;padding-right: 0px">
  <img src="/images/Binding_pocket/Tobramycin_aptamer_binding_pocker3.svg" alt="drawing" style="width:500px;margin-top: 0px;margin-bottom: 0px;" >
  </td>
  <td style="text-align:center;padding-bottom: 0px;padding-right: 0px;padding-top: 0px;padding-right: 0px">
  <img src="/images/Binding_pocket/Tobramycin_aptamer_binding_pocker4.svg" alt="drawing" style="width:500px;margin-top: 0px;margin-bottom: 0px;" >
  </td>
  </tr>
  </table>
  <br>
  <br>
  


<p class="header_box" id="ligand-recognition">Ligand information</p>
  
<p class="blowheader_box">SELEX ligand</p>
<p>Rando, R. R. et al. used a variety of methods, including cloned RNA fluorescence, equilibrium gel filtration, and polymerase chain reaction (PCR) to determine the affinity of tobramycin RNA aptamer in solution<sup>[<a href="#ref1" style="color:#520049">1</a>]</sup>.</p>
<div style="display: flex; justify-content: center;"></div>
  <img src="/images/SELEX_ligand/Tobramycin_SELEX_ligand.svg" alt="drawing" style="width:1000px;height:400px;border:solid 1px #efefef!important;display:block;margin:0 auto;border:solid 1px;border-radius:0;" class="img-responsive">
<br>


<p class="blowheader_box">Structure ligand</p>
<p>Tobramycin is an aminoglycoside antibiotic used to treat cystic fibrosis-associated bacterial, lower respiratory tract, urinary tract, eye, skin, bone, and skin structure infections.-----From <a href="https://go.drugbank.com/drugs/DB00684" target="_blank" style="color:#520049; text-decoration: underline;"><b>Drugbank</b></a></p>

<p class="dot-paragraph"><b>PubChem CID:</b> a unique identifier for substances in the <a href="https://pubchem.ncbi.nlm.nih.gov/" target="_blank" style="color:#520049; text-decoration: underline;"><b>PubChem database</b></a>.</p>
<p class="dot-paragraph"><b><a href="https://commonchemistry.cas.org/" target="_blank" style="color:#520049; text-decoration: underline;"><b>CAS</b></a> number:</b> a global registry number for chemical substances.</p>
<p class="dot-paragraph"><b><a href="https://go.drugbank.com/" target="_blank" style="color:#520049; text-decoration: underline;"><b>Drugbank</b></a>:</b> a comprehensive database with detailed information on drugs and drug targets.</p>

<table class="table table-bordered" style="table-layout:fixed;width:auto;margin-left:auto;margin-right:auto;" >
  <thead>
      <tr>
        <th onclick="sortTable(6)">Name</th>
        <th onclick="sortTable(0)">PubChem CID</th>
        <th onclick="sortTable(1)">Molecular Formula</th>
        <th onclick="sortTable(2)">Molecular Weight</th>
        <th onclick="sortTable(3)">CAS</th>
        <th onclick="sortTable(4)">Solubility</th>
        <th onclick="sortTable(5)">Drugbank ID</th>
      </tr>
  </thead>
    <tbody>
      <tr>
        <td name="td6">Tobramycin</td>
        <td name="td0"><a href="https://pubchem.ncbi.nlm.nih.gov/compound/36294" target="_blank" style="color:#520049"><b>36294</b></a></td>
        <td name="td1">C<sub>18</sub>H<sub>37</sub>N<sub>5</sub>O<sub>9</sub></td>
        <td name="td2">467.5 g/mol</td>
        <td name="td3"><a href="https://commonchemistry.cas.org/detail?cas_rn=32986-56-4" target="_blank" style="color:#520049"><b>32986-56-4</b></a></td>
        <td name="td4">5.37e+01 g/L</td>
        <td name="td5"><a href="https://go.drugbank.com/drugs/DB00684" target="_blank" style="color:#520049"><b>DB00684</b> </a></td>
      </tr>
	  </tbody>
  </table>
<table class="table table-bordered" style="table-layout:fixed;width:auto;margin-left:auto;margin-right:auto;"><tr>
<td style="text-align:center;padding-bottom: 0px;padding-left: 0px;padding-top: 0px;padding-right: 0px"><img src="/images/Structure_ligand/Tobramycin_stru_ligand1.svg" alt="drawing" style="width:400px"  px="" /></td>
<td style="text-align:center;padding-bottom: 0px;padding-left: 0px;padding-top: 0px;padding-right: 0px"><img src="/images/Structure_ligand/Tobramycin_stru_ligand2.svg" alt="drawing" style="width:400px"  px="" /></td>
</tr>
</table>
<div style="display: flex; justify-content: center;"></div>

              
<p class="blowheader_box">Similar compound(s)</p>
<p>We screened the compounds with great similarity toTobramycin by using the <a href="https://zinc15.docking.org/" target="_blank" style="color:#520049; text-decoration: underline;"><b>ZINC database</b></a> and showed some of the compounds' structure diagrams. For some CAS numbers not available, we will supplement them with Pubchem CID.</p>

<p class="dot-paragraph"><b>ZINC ID:</b> a compound identifier used by the <a href="https://zinc15.docking.org/" target="_blank" style="color:#520049; text-decoration: underline;"><b>ZINC database</b></a>, one of the largest repositories for virtual screening of drug-like molecules.</p>
<p class="dot-paragraph"><b>PubChem CID:</b> a unique identifier for substances in the <a href="https://pubchem.ncbi.nlm.nih.gov/" target="_blank" style="color:#520049; text-decoration: underline;"><b>PubChem database</b></a>.</p>
<p class="dot-paragraph"><b><a href="https://commonchemistry.cas.org/" target="_blank" style="color:#520049; text-decoration: underline;"><b>CAS</b></a> number:</b> a global registry number for chemical substances.</p>

<table class="table table-bordered" style="table-layout:fixed;width:auto;margin-left:auto;margin-right:auto;" >
  <thead>
      <tr>
        <th onclick="sortTable(1)">ZINC ID</th>
        <th onclick="sortTable(2)">Name</th>
        <th onclick="sortTable(3)">CAS</th>
        <th onclick="sortTable(4)">Pubchem CID</th>
        <th onclick="sortTable(5)">Structure</th>
      </tr>
  </thead>
    <tbody>
      <tr>
        <td name="td1"><a href="https://zinc15.docking.org/substances/ZINC8551162/" target="_blank" style="color:#520049"><b>ZINC8551162</b></a></td>
        <td name="td2">(2R,3S,4R,5S,6S)-4-amino-2-[(1R,2R,3R,4S,6R)-4,6-diamino-3-[(2S,3S,5S,6S)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-dio</td>
        <td name="td3">NA</td>
        <td name="td4"><a href="https://pubchem.ncbi.nlm.nih.gov/compound/92331686" target="_blank" style="color:#520049"><b>92331686</b></a></td>
        <td name="td5"><img src="/images/Similar_compound/Tobramycin_Simi_compound1.svg" alt="drawing" style="width:500px"  px="" /></td>
      </tr>
      <tr>
        <td name="td1"><a href="https://zinc15.docking.org/substances/ZINC8551164/" target="_blank" style="color:#520049"><b>ZINC8551164</b></a></td>
        <td name="td2">(2R,3S,4R,5S,6S)-4-amino-2-[(1R,2R,3R,4S,6R)-4,6-diamino-3-[(2R,3S,5S,6S)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol</td>
        <td name="td3">NA</td>
        <td name="td4"><a href="https://pubchem.ncbi.nlm.nih.gov/compound/92331688" target="_blank" style="color:#520049"><b>92331688</b></a></td>
        <td name="td5"><img src="/images/Similar_compound/Tobramycin_Simi_compound2.svg" alt="drawing" style="width:500px"  px="" /></td>
      </tr>
      <tr>
        <td name="td1"><a href="https://zinc15.docking.org/substances/ZINC8551165/" target="_blank" style="color:#520049"><b>ZINC8551165</b></a></td>
        <td name="td2">(2R,3S,4R,5S,6S)-4-amino-2-[(1R,2R,3R,4S,6R)-4,6-diamino-3-[(2R,3S,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol</td>
        <td name="td3">NA</td>
        <td name="td4"><a href="https://pubchem.ncbi.nlm.nih.gov/compound/92331689" target="_blank" style="color:#520049"><b>92331689</b></a></td>
        <td name="td5"><img src="/images/Similar_compound/Tobramycin_Simi_compound3.svg" alt="drawing" style="width:500px"  px="" /></td>
      </tr>
      <tr>
        <td name="td1"><a href="https://zinc15.docking.org/substances/ZINC8551163/" target="_blank" style="color:#520049"><b>ZINC8551163</b></a></td>
        <td name="td2">(2R,3S,4R,5S,6S)-4-amino-2-[(1R,2R,3R,4S,6R)-4,6-diamino-3-[(2S,3S,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol</td>
        <td name="td3">NA</td>
        <td name="td4"><a href="https://pubchem.ncbi.nlm.nih.gov/compound/92331687" target="_blank" style="color:#520049"><b>92331687</b></a></td>
        <td name="td5"><img src="/images/Similar_compound/Tobramycin_Simi_compound4.svg" alt="drawing" style="width:500px"  px="" /></td>
      </tr>
      <tr>
        <td name="td1"><a href="https://zinc15.docking.org/substances/ZINC8214692/" target="_blank" style="color:#520049"><b>ZINC8214692</b></a></td>
        <td name="td2">Tobramycin</td>
        <td name="td3"><a href="https://commonchemistry.cas.org/detail?cas_rn=32986-56-4" target="_blank" style="color:#520049"><b>32986-56-4</b></a></td>
        <td name="td4"><a href="https://pubchem.ncbi.nlm.nih.gov/compound/36294" target="_blank" style="color:#520049"><b>36294</b></a></td>
        <td name="td5"><img src="/images/Similar_compound/Tobramycin_Simi_compound5.svg" alt="drawing" style="width:500px"  px="" /></td>
      </tr>
      <tr>
        <td name="td1"><a href="https://zinc15.docking.org/substances/ZINC43562055/" target="_blank" style="color:#520049"><b>ZINC43562055</b></a></td>
        <td name="td2">(2S,3R,4R,5S,6S)-2-(Aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-3-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol</td>
        <td name="td3">NA</td>
        <td name="td4"><a href="https://pubchem.ncbi.nlm.nih.gov/compound/11274101" target="_blank" style="color:#520049"><b>11274101</b></a></td>
        <td name="td5"><img src="/images/Similar_compound/Tobramycin_Simi_compound6.svg" alt="drawing" style="width:500px"  px="" /></td>
      </tr>
      <tr>
        <td name="td1"><a href="https://zinc15.docking.org/substances/ZINC8214590/" target="_blank" style="color:#520049"><b>ZINC8214590</b></a></td>
        <td name="td2">Kanamycin</td>
        <td name="td3"><a href="https://commonchemistry.cas.org/detail?cas_rn=59-01-8" target="_blank" style="color:#520049"><b>59-01-8</b></a></td>
        <td name="td4"><a href="https://pubchem.ncbi.nlm.nih.gov/compound/6032" target="_blank" style="color:#520049"><b>6032</b></a></td>
        <td name="td5"><img src="/images/Similar_compound/Tobramycin_Simi_compound7.svg" alt="drawing" style="width:500px"  px="" /></td>
      </tr>
      <tr>
        <td name="td1"><a href="https://zinc15.docking.org/substances/ZINC53132258/" target="_blank" style="color:#520049"><b>ZINC53132258</b></a></td>
        <td name="td2">Bekanamycin</td>
        <td name="td3"><a href="https://commonchemistry.cas.org/detail?cas_rn=4696-76-8" target="_blank" style="color:#520049"><b>4696-76-8</b></a></td>
        <td name="td4"><a href="https://pubchem.ncbi.nlm.nih.gov/compound/439318" target="_blank" style="color:#520049"><b>439318</b></a></td>
        <td name="td5"><img src="/images/Similar_compound/Tobramycin_Simi_compound8.svg" alt="drawing" style="width:500px"  px="" /></td>
      </tr>
      <tr>
        <td name="td1"><a href="https://zinc15.docking.org/substances/ZINC8214383/" target="_blank" style="color:#520049"><b>ZINC8214383</b></a></td>
        <td name="td2">Dibekacin</td>
        <td name="td3"><a href="https://commonchemistry.cas.org/detail?cas_rn=34493-98-6" target="_blank" style="color:#520049"><b>34493-98-6</b></a></td>
        <td name="td4"><a href="https://pubchem.ncbi.nlm.nih.gov/compound/470999" target="_blank" style="color:#520049"><b>470999</b></a></td>
        <td name="td5"><img src="/images/Similar_compound/Tobramycin_Simi_compound9.svg" alt="drawing" style="width:500px"  px="" /></td>
      </tr>
	  </tbody>
  </table>



                 
<p class="header_box" id="references">References</p>
                
<a id="ref1"></a><font><strong>[1] Specific binding of aminoglycoside antibiotics to RNA.</strong></font><br />
Wang, Y., & Rando, R. R.<br />
<a href="https://pubmed.ncbi.nlm.nih.gov/9383430/" target="_blank" style="color:#520049" > Chemistry & biology, 2(5), 281–290. (1995)</a>
<br />
                
<a id="ref2"></a><font><strong>[2] Accharide-RNA recognition in an aminoglycoside antibiotic-RNA aptamer complex.</strong></font><br />
Jiang, L., Suri, A. K., Fiala, R., & Patel, D. J.<br />
<a href="https://pubmed.ncbi.nlm.nih.gov/9070426/" target="_blank" style="color:#520049"> SChemistry & biology, 4(1), 35–50. (1997)</a>
<br />
                
<a id="ref3"></a><font><strong>[3] Solution structure of the tobramycin-RNA aptamer complex.</strong></font><br />
Jiang, L., & Patel, D. J. <br />
<a href="https://pubmed.ncbi.nlm.nih.gov/9731769/" target="_blank" style="color:#520049"> Nature structural biology, 5(9), 769–774. (1998)</a>
<br />
                
<a id="ref4"></a><font><strong>[4] Tobramycin affinity tag purification of spliceosomes.</strong></font><br />
Hartmuth, K., Vornlocher, H. P., & Lührmann, R. <br />
<a href="https://pubmed.ncbi.nlm.nih.gov/14769995/" target="_blank" style="color:#520049">Methods in molecular biology (Clifton, N.J.), 257, 47–64. (2004)</a>
<br />
                
<a id="ref5"></a><font><strong>[5] Electrospray ionization of nucleic acid aptamer/small molecule complexes for screening aptamer selectivity.</strong></font><br />
Keller, K. M., Breeden, M. M., Zhang, J., Ellington, A. D., & Brodbelt, J. S.<br />
<a href="https://pubmed.ncbi.nlm.nih.gov/16217837/" target="_blank" style="color:#520049">Journal of mass spectrometry : JMS, 40(10), 1327–1337. (2005)</a>
<br />
                
<a id="ref6"></a><font><strong>[6] Achieving reproducible performance of electrochemical, folding aptamer-based sensors on microelectrodes: challenges and prospects.</strong></font><br />
Liu, J., Wagan, S., Dávila Morris, M., Taylor, J., & White, R. J. <br />
<a href="https://pubmed.ncbi.nlm.nih.gov/25337781/" target="_blank" style="color:#520049">Analytical chemistry, 86(22), 11417–11424. (2014)</a>
<br />
                
<a id="ref7"></a><font><strong>[7] Rationally designing aptamer sequences with reduced affinity for controlled sensor performance.</strong></font><br />
Schoukroun-Barnes, L. R., & White, R. J.<br />
<a href="https://pubmed.ncbi.nlm.nih.gov/25835184/" target="_blank" style="color:#520049">Sensors (Basel, Switzerland), 15(4), 7754–7767. (2015)</a>
<br />
                
<a id="ref8"></a><font><strong>[8] Gold nanoparticle based photometric determination of tobramycin by using new specific DNA aptamers.</strong></font><br />
Han, X., Zhang, Y., Nie, J., Zhao, S., Tian, Y., & Zhou, N.<br />
<a href="https://pubmed.ncbi.nlm.nih.gov/29594665/" target="_blank" style="color:#520049">Mikrochimica acta, 185(1), 4. (2017)</a>
<br />
                
<a id="ref9"></a><font><strong>[9] Aptamer-enabled uptake of small molecule ligands.</strong></font><br />
Auwardt, S. L., Seo, Y. J., Ilgu, M., Ray, J., Feldges, R. R., Shubham, S., Bendickson, L., Levine, H. A., & Nilsen-Hamilton, M.<br />
<a href="https://pubmed.ncbi.nlm.nih.gov/30356136/" target="_blank" style="color:#520049">Scientific reports, 8(1), 15712. (2018)</a>
<br />
                
<a id="ref10"></a><font><strong>[10] Electrochemical detection of tobramycin based on enzymes-assisted dual signal amplification by using a novel truncated aptamer with high affinity.</strong></font><br />
Nie, J., Yuan, L., Jin, K., Han, X., Tian, Y., & Zhou, N. <br />
<a href="https://pubmed.ncbi.nlm.nih.gov/30268963/" target="_blank" style="color:#520049">Biosensors & bioelectronics, 122, 254–262. (2018)</a>
<br />
                
<a id="ref11"></a><font><strong>[11] Creening, Post-SELEX Optimization and Application of DNA Aptamers Specific for Tobramycin.</strong></font><br />
Zhou, N., Cai, R., & Han, X.  S. <br />
<a href="https://pubmed.ncbi.nlm.nih.gov/31625087/" target="_blank" style="color:#520049" >Methods in molecular biology (Clifton, N.J.), 2070, 1–18 (2020)</a>
<br />

<a id="ref12"></a><font><strong>[12] Structure-switching aptamer triggering signal amplification strategy for tobramycin detection based on hybridization chain reaction and fluorescence synergism.</strong></font><br />
Wang, J., Li, H., Du, C., Li, Y., Ma, X., Yang, C., Xu, W., & Sun, C. <br />
<a href="https://pubmed.ncbi.nlm.nih.gov/35217273/" target="_blank" style="color:#520049" >Talanta, 243, 123318. (2022)</a>
<br />

<a id="ref13"></a><font><strong>[13] Development of a novel tobramycin dependent riboswitch.</strong></font><br />
Kraus, L., Duchardt-Ferner, E., Bräuchle, E., Fürbacher, S., Kelvin, D., Marx, H., Boussebayle, A., Maurer, L. M., Bofill-Bosch, C., Wöhnert, J., & Suess, B.<br />
<a href="https://pubmed.ncbi.nlm.nih.gov/37791877/" target="_blank" style="color:#520049" > Nucleic acids research, 51(20), 11375–11385. (2023)</a>
<br />

